Imaging HSP90 Inhibitor AUY922 on VEGF-89ZR-bevacizumab Positron Emission Tomography (PET)
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Breast Cancer
Interventions: OTHER: 89Zr-bevacizumab PET imaging
Sponsor: University Medical Center Groningen